← Open Payments lookup

GLORIA BARNETT-DUNCAN: Open Payments

NPI 1346627064 · HYANNIS, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,344 in 48 payments from 14 companies in 2025. Trend: 2023 $587 · 2024 $595 · 2025 $1,344

Food & beverage: $1,344
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.15$415
Axsome Therapeutics, Inc.3$179
Vanda Pharmaceuticals Inc.6$153
E.R. Squibb & Sons, L.L.C.4$106
ABBVIE INC.4$99
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$97
Teva Pharmaceuticals USA, Inc.4$83
Janssen Pharmaceuticals, Inc2$57
Luye Pharma (USA) Ltd.2$37
Neurocrine BioSciences, Inc.1$28

Products named: REXULTI, Auvelity, FANAPT, COBENFY, VRAYLAR, CAPLYTA, AUSTEDO XR, INVEGA SUSTENNA.

Industry payments across MA — which companies pay providers there.